Chemoinformaics analysis of Digitoxigenin-Alpha-L-Cymaroside
| Molecular Weight | 518.691 | nRot | 4 |
| Heavy Atom Molecular Weight | 472.323 | nRig | 31 |
| Exact Molecular Weight | 518.324 | nRing | 6 |
| Solubility: LogS | -4.793 | nHRing | 2 |
| Solubility: LogP | 3.564 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 86.3865 |
| nHD | 2 | BPOL | 53.9595 |
| QED | 0.476 |
| Synth | 5.18 |
| Natural Product Likeliness | 2.602 |
| NR-PPAR-gamma | 0.32 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.189 |
| Pgp-sub | 0.007 |
| HIA | 0.012 |
| CACO-2 | -4.85 |
| MDCK | 0.0000516 |
| BBB | 0.482 |
| PPB | 0.979225 |
| VDSS | 1.862 |
| FU | 0.0200169 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.883 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.846 |
| CYP2c9-inh | 0.099 |
| CYP2c9-sub | 0.213 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.802 |
| CYP3a4-inh | 0.109 |
| CYP3a4-sub | 0.562 |
| CL | 21.532 |
| T12 | 0.046 |
| hERG | 0.452 |
| Ames | 0.026 |
| ROA | 0.984 |
| SkinSen | 0.582 |
| Carcinogencity | 0.069 |
| EI | 0.007 |
| Respiratory | 0.94 |
| NR-Aromatase | 0.815 |
| Antiviral | Yes |
| Prediction | 0.646025 |